Hi All !! Sorry I've been away so long, but I've been under "gag orders". Now, for clarification....
1. 40 vs 17 % is well above FDA approvable numbers. Impotency drugs have a historically high placebo.
2. 40% success was attained with the highest average age of all trials, 59 years. Since the older the subject, the lower the success rate, that number is even MORE impressive.
3. The Second grouping of the Phase III may indeed change the numbers, better or worse. One would believe, however, that in an accurately controlled trial (the Pval of less than .001 shows that fact), these numbers shouldn't change much.
4. When a Company changes their clinical endpoints, there MAY be cause for alarm. In this case, however, the endpoint was changed to accomodate the FDA. For the laymen, just try to image how hard it is to get Governmet approval after ignoring their less-than-subtle suggestions. Translation: DO WHAT THE FDA SAYS, OR, NOMATTER HOW GOOD YOUR DRUG IS, IT AIN'T SELLING.
5. Why all this comparison to VIVUS ? Let's face it, If ZONA has a lower success rate than VVUS, which it does, wouldn't you STILL rather try the pill before you go shoving pellets down your willie??? (remember the KISS theory: KEEP IT SIMPLE, STUPID!)
6. ZONA GAVE NO FOLLOW-UP DATA The stock deserves to fall !! But, unless the IMPORTANT numbers are way off (ie 40 vs 17%), the follow up data will validate the endpoints. Guess what happens?? The stock goes WAY OVER 24 1/4.
7. TOXICITY: 1 adverse event in an abuse situation is usually ignored by the FDA, especially when it doesn't cause permanent harm.
8. VIAGRA: Is the PFE drug better??? Show me the data!!! (if any of you DARE to show me stale, year-old Phase II data should have your chat-room privileges taken away!!!) I hear it ain't all its cracked-up to be.
Well I'm sure I have more I meant to say, but the bottom line is this: The stock will be choppy for the next couple or weeks, until the validated data is out. But, any of you who listen to Steve Shobin, or Walay-I-Think-VVUS-Is-Worth-$100-Bucks-A-Share- Because-I-Like-Shoving-Things-In-My-Schlong-Fayeme (I bet I spelled his name wrong, and I don't care!!) or Elliot, his salesman parrot, should have hs head examined, and I don't mean the impotent one!!! BUY and HOLD!!!!! |